Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
As artificial intelligence becomes increasingly integrated into education, both students and faculty are grappling with the question ‘How can AI support learning?’ UW’s generative AI policies vary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results